Industry Events
EnglishFrançaisEspañol中文العربية
活动新闻行业洞察主办方
服务
  • 活动营销向全球B2B受众发布、推广并拓展您的活动。
  • 新闻稿向全球行业专业人士分发官方公告。
  • 演讲者与专家推广展示您的专业知识,获得主旨演讲、专题讨论和大师班邀约。
订阅
演讲者登录免费发布您的活动
Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF101.6.
  • 活动
  • 新闻
  • 行业洞察
  • 账户
Industry Events
EnglishFrançaisEspañol中文العربية
活动新闻行业洞察主办方
服务
  • 活动营销向全球B2B受众发布、推广并拓展您的活动。
  • 新闻稿向全球行业专业人士分发官方公告。
  • 演讲者与专家推广展示您的专业知识,获得主旨演讲、专题讨论和大师班邀约。
订阅
演讲者登录免费发布您的活动
  1. 首页
  2. 新闻
  3. STAT+: Seattle scientists launch $95 million AI biology effort

STAT News

STAT+: Seattle scientists launch $95 million AI biology effort

Ultragenyx drug fails pivotal Phase 3, FDA's success at regulating unproven stem cells, and other biotech news

前往出版商网站继续阅读完整报道。

在 STAT News 阅读全文
S

作者 STAT News

3 September 2026|1 分钟阅读
分享
Health Tech
STAT+: Seattle scientists launch $95 million AI biology effort
STAT+: Seattle scientists launch $95 million AI biology effort
分享
← 返回 IE News

有活动行业的新闻要分享吗?

提交新闻稿或信息,触达数千名活动行业专业人士。

联系我们→

更多Health Tech相关内容

  • STAT+: Recipients of gene-edited pig kidneys successfully receive human organs

    STAT News

    STAT+: Recipients of gene-edited pig kidneys successfully receive human organs

    3 September 2026
  • STAT+: OpenEvidence launches new family of AI models

    STAT News

    STAT+: OpenEvidence launches new family of AI models

    3 September 2026
  • STAT+: ARPA-H funds biotechs working on custom RNA therapies

    STAT News

    STAT+: ARPA-H funds biotechs working on custom RNA therapies

    2 September 2026
  • STAT+: Abivax has still not been acquired. What’s going on?

    STAT News

    STAT+: Abivax has still not been acquired. What’s going on?

    3 September 2026
  • STAT+: How Trump’s latest pharma deals may undermine efforts to rein in drug costs

    STAT News

    STAT+: How Trump’s latest pharma deals may undermine efforts to rein in drug costs

    2 September 2026
  • STAT+: Pharmalittle: We’re reading about a Huntington’s gene therapy, Novo’s challenges, and more

    STAT News

    STAT+: Pharmalittle: We’re reading about a Huntington’s gene therapy, Novo’s challenges, and more

    2 September 2026

相关洞察

  • Advanced manufacturing and industrial AI

    Rare Earth Elements: The Invisible Engine of Modern Life

    11 Aug 202610 min read
  • Smart agriculture and food technology

    The Future of Food: Vertical & Indoor Farming Is Becoming a Serious Growth Industry

    Vertical farming cuts water use 90%, grows food anywhere, anytime—and with costs plummeting, it’s both a climate lifeline and a trillion-dollar investment bet.

    2 Aug 202610 min read
  • Precision medicine and longevity

    AI Series: Predictive HealthCare

    Predictive and Preventive medicine is quietly rewiring how care works. Here's what's changing, what's real, and how to get ahead of it.

    28 Jul 202614 min read
Browse all insights →

相关活动

  • Project Finance & Project Financial Modelling - Oct 2026

    19 Oct 2025
  • ADIHEX 2026 (Abu Dhabi International Hunting and Equestrian Exhibition)

    28 Aug 2026
    Abu Dhabi, United Arab Emirates
  • International Built Environment Week (IBEW) 2026

    2 Sept 2026
    Singapore
  • BeautyEurasia

    2 Sept 2026
    Turkey
浏览所有活动→

更多新闻中心内容

  • Opinion: The next DSM should address the algorithm’s role in eating disorders

    Opinion: The next DSM should address the algorithm’s role in eating disorders

    2 September 2026
  • STAT+: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder

    STAT+: Ionis wins FDA approval for first drug for Alexander disease, a rare and deadly neurological disorder

    3 September 2026
  • STAT+: Fauci speaks, and writes

    STAT+: Fauci speaks, and writes

    3 September 2026
  • STAT+: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial

    STAT+: Ultragenyx drug to treat Angelman syndrome, a rare disease, fails late-stage trial

    2 September 2026
Industry Events

全球最值得信赖的B2B活动发现平台。将行业专业人士与重要的会议、展会和峰会连接起来。

  • Industry Events
  • 新闻
  • 活动主办方
  • 关于我们
  • 我们的服务
  • 高级主办方
  • Event Pro
  • 成为演讲者
  • 订阅
  • 使用条款
  • 隐私政策

© 2026 Industry Events Worldwide。保留所有权利。

VF101.6.